RBC Microcap Value Fund Class A
TMVAX
NASDAQ
| Weiss Ratings | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B- | |||
| Company Info | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | RBC Global Asset Management. | |||
| Manager/Tenure (Years) | Lance F. James (16), Murphy O'Flaherty (2) | |||
| Website | http://www.rbcgam.us | |||
| Fund Information | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | RBC Microcap Value Fund Class A | |||
| Category | Small Value | |||
| Sub-Category | US Equity Small Cap | |||
| Prospectus Objective | Small Company | |||
| Inception Date | Apr 19, 2004 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.60% | |||
| Dividend | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.40% | |||
| Asset Allocation | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.40% | |||
| Stock | 98.46% | |||
| U.S. Stock | 96.72% | |||
| Non-U.S. Stock | 1.74% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.13% | |||
| Price History | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 5.26% | |||
| 30-Day Total Return | 8.94% | |||
| 60-Day Total Return | 11.33% | |||
| 90-Day Total Return | 16.83% | |||
| Year to Date Total Return | 1.59% | |||
| 1-Year Total Return | 17.13% | |||
| 2-Year Total Return | 28.46% | |||
| 3-Year Total Return | 36.13% | |||
| 5-Year Total Return | 113.50% | |||
| Price | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $27.41 | |||
| 1-Month Low NAV | $25.29 | |||
| 1-Month High NAV | $27.41 | |||
| 52-Week Low NAV | $22.14 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $31.62 | |||
| 52-Week High Price (Date) | Nov 25, 2024 | |||
| Beta / Standard Deviation | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.84 | |||
| Standard Deviation | 21.08 | |||
| Balance Sheet | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 105.52M | |||
| Operating Ratios | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.34% | |||
| Turnover Ratio | 22.00% | |||
| Performance | TMVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 24.52% | |||
| Last Bear Market Total Return | -9.88% | |||